Dermatitis, Atopic: all 1,443 studies

Page 10 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid ArthritisStatus unknownNCT04815148Phase 1
• Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04805411Phase 2
• Characterizing Skin Microbiome Change in Atopic DermatitisCompletedNCT04800185Early Phase 1
• Systems Biology of Early AtopyActive, not recruitingNCT04798079
• A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)CompletedNCT04772885Phase 1
• Study on Hypoallergenic Hair DyeCompletedNCT04772482
• Study of the Skin Microbiome and the Potential of a Topical Probiotic Cream for Atopic DermatitisStatus unknownNCT04771910Not applicable
• Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)CompletedNCT04763512Not applicable
• Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic DermatitisWithdrawnNCT04761978
• A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and ChildrenCompletedNCT04740892Not applicable
• An Innovative Probiotic Product With Antiallergic PropertiesCompletedNCT04738565Not applicable
• A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic DermatitisCompletedNCT04737304Phase 1/2
• Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic DermatitisCompletedNCT04728269Not applicable
• Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic DermatitisStatus unknownNCT04725136Phase 1/2
• Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic DermatitisActive, not recruitingNCT04717310Phase 2/3
• Staphylococcus Aureus in Atopic Dermatitis ImmunopathologyCompletedNCT04715087Not applicable
• Efficacy of Oral Supplementation of Probiotics in Children With Atopic DermatitisCompletedNCT04706559Not applicable
• A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic DermatitisCompletedNCT04693195Phase 2
• The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal MedicineCompletedNCT04686955Phase 3
• Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencingStatus unknownNCT04681300
• Dupilumab in Japanese Patients With Atopic DermatitisCompletedNCT04678882Phase 3
• A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in BrazilWithdrawnNCT04666675Phase 3
• A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic DermatitisCompletedNCT04662619Not applicable
• A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic DermatitisCompletedNCT04643457Phase 1/2
• Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic DermatitisCompletedNCT04635072Early Phase 1
• Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From EczemaStatus unknownNCT04617977Not applicable
• Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.Status unknownNCT04615962Phase 1
• Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic DermatitisCompletedNCT04613037Early Phase 1
• A First-in-Human Study of CEE321 in Adult SubjectsCompletedNCT04612062Phase 1
• Skin Barrier Abnormalities and Oxidative Stress ResponseStatus unknownNCT04606615
• Goat Infant Formula Feeding and Eczema (the GIraFFE Study)Active, not recruitingNCT04599946Not applicable
• Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic DermatitisNo longer availableNCT04564755
• Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier FunctionCompletedNCT04556461Phase 2
• Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic DermatitisCompletedNCT04553224Not applicable
• Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic DermatitisCompletedNCT04544943Phase 1
• A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic ArthritisCompletedNCT04541810
• Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic DermatitisCompletedNCT04539639Phase 2
• Development of a Method to Measure mRNA Levels in Skin SamplesCompletedNCT04537468Not applicable
• A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)CompletedNCT04530643Phase 2
• Hand Sanitizer Effects on the Skin BarrierStatus unknownNCT04525521
• An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic DermatitisStatus unknownNCT04520308Phase 4
• Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic DermatitisCompletedNCT04504279Phase 2
• Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory DermatosisCompletedNCT04472546Not applicable
• Vitamin D in Egyptian Children With Atopic DermatitisCompletedNCT04468711Phase 3
• Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic DermatitisTerminatedNCT04462055
• Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.CompletedNCT04444726Not applicable
• Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic DermatitisCompletedNCT04440410
• Jaktinib Hydrochloride Cream For Atopic DermatitisCompletedNCT04435392Phase 1/2
• Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic DermatitisStatus unknownNCT04413942Phase 2
• Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early ChildhoodStatus unknownNCT04398758Phase 3
• A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis PatientsCompletedNCT04369846Phase 1/2
• Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic DermatitisCompletedNCT04362852
• Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and AsthmaStatus unknownNCT04354207
• A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis PatientsCompletedNCT04352595Phase 2
• Clinic-Based Atopic Dermatitis Therapeutic Patient EducationCompletedNCT04352270Not applicable
• Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate ADCompletedNCT04339985Phase 2
• Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist NaltrexoneWithdrawnNCT04325802Phase 2
• Comprehending Atopic Risk ElementsStatus unknownNCT04325451
• The Role of IL-22/IL-22BP Axis in Atopic DermatitisCompletedNCT04310189Not applicable
• The Effectiveness of Antibacterial Therapeutic Clothing Based on Silver or Chitosan as Compared With Non-antibacterial Therapeutic Clothing in Patients With Moderate to Severe Atopic DermatitisStatus unknownNCT04297215Not applicable
• Skin Pathology Assessment With Optical TechnologiesCompletedNCT04295824
• Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic DermatitisCompletedNCT04287608
• Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic DermatitisStatus unknownNCT04283968Phase 3
• Staphylococcal Toxins in Atopic Dermatitis and Eczema HerpeticumCompletedNCT04274348Not applicable
• A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic DermatitisCompletedNCT04271514Phase 1
• Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone FuroatesCompletedNCT04271007Phase 4
• Topical L. Reuteri in Children With Atopic DermatitisStatus unknownNCT04265716Not applicable
• A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)TerminatedNCT04262791Phase 1
• A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic DermatitisCompletedNCT04256174Phase 1
• The Factors Affecting Atopic Dermatitis in Children Age 1-3CompletedNCT04218877
• Study of Crisaborole Ointment 2% in Mild to Moderate Atopic DermatitisStatus unknownNCT04214197Phase 4
• Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic DermatitisTerminatedNCT04211415Phase 1
• Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic DermatitisCompletedNCT04193670Not applicable
• Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. PlaceboTerminatedNCT04192513Phase 2
• Skin Tape Transcriptome Methods in ChildrenCompletedNCT04180644
• Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT04179760Phase 1/2
• Stress-induced Scratching in Healthy and ADCompletedNCT04174651Not applicable
• Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected PregnancyCompletedNCT04173442
• Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate EczemaCompletedNCT04156191Phase 1
• Epidemiological Survey and Genetic Analysis of AD Patients in Hong KongStatus unknownNCT04154839
• Treatment of Chronic Itch in Atopic Dermatitis With Topical NaltrexoneWithdrawnNCT04154033Phase 2
• Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic DermatitisActive, not recruitingNCT04137562Phase 2
• A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy ParticipantsCompletedNCT04135560Phase 1
• The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone TurnoverCompletedNCT04114097Phase 4
• A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic DermatitisTerminatedNCT04110873Phase 2
• Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier FunctionCompletedNCT04097327
• A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic DermatitisCompletedNCT04090229Phase 1
• Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis PatientsStatus unknownNCT04087863
• Effects of a Berry Oil Cream on Atopic Eczema and SkinTerminatedNCT04085549Not applicable
• A Study of LY3471851 in Participants With EczemaCompletedNCT04081350Phase 1
• Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial FormulationCompletedNCT04065633Phase 1
• Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema HerpeticumStatus unknownNCT04060550
• Response of Children With Atopic Dermatitis (Eczema) to EucrisaCompletedNCT04023084Phase 4
• The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard TherapyStatus unknownNCT04018131Phase 3
• Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic DermatitisCompletedNCT04018027Phase 2
• Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)CompletedNCT04011215Not applicable
• Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week PeriodCompletedNCT04008784
• Evaluating the Effect of Bathing Additives in Atopic DermatitisTerminatedNCT04001855Not applicable
• Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)Active, not recruitingNCT03992417
• Evalution the Safety and Efficacy in Atopic Dermatitis PatientsStatus unknownNCT03962387

← Dermatitis, Atopic overview